Noradrenergic stimulation and motor performance: Differential effects of reboxetine on movement kinematics and visuomotor abilities in healthy human subjects

Neuropsychologia

Volumn 47, Issue 5, 2009, Pages 1302-1312

  Wang, Ling E ^a,b   Fink, Gereon R ^a,c   Dafotakis, Manuel ^a   Grefkes, Christian ^a,c,d  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Human motor system; Kinematics; Reboxetine; Recovery of function; Visuomotor

Indexed keywords

ADRENERGIC UPTAKE INHIBITORS; ADULT; BIOMECHANICS; FEMALE; HEMODYNAMICS; HUMANS; MALE; MORPHOLINES; PSYCHOMOTOR PERFORMANCE;

EID: 61849148823     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2009.01.024     Document Type: Article

References (60)

1. Aston-Jones G., Rajkowski J., and Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biological Psychiatry 46 (1999) 1309-1320
2. Azzaro A.J., and Rutledge C.O. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat-brain. Biochemical Pharmacology 22 (1973) 2801-2813
3. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Research Brain Research Reviews 42 (2003) 33-84
4. Boyeson M.G., and Feeney D.M. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacology Biochemistry and Behavior 35 (1990) 497-501
5. Breitenstein C., Wailke S., Bushuven S., Kamping S., Zwitserlood P., Ringelstein E.B., et al. D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology 29 (2004) 1704-1714
6. Butefisch C.M., Davis B.C., Sawaki L., Waldvogel D., Classen J., Kopylev L., et al. Modulation of use-dependent plasticity by D-amphetamine. Annals of Neurology 51 (2002) 59-68
7. Chen R., Cohen L.G., and Hallett M. Nervous system reorganization following injury. Neuroscience 111 (2002) 761-773
8. Classen J., Liepert J., Wise S.P., Hallett M., and Cohen L.G. Rapid plasticity of human cortical movement representation induced by practice. Journal of Neurophysiology 79 (1998) 1117-1123
9. Clayton E.C., Rajkowski J., Cohen J.D., and Aston-Jones G. Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task. Journal of Neuroscience 24 (2004) 9914-9920
10. Corbetta M., and Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nature Reviews Neuroscience 3 (2002) 201-215
11. Cotzias G.C., Papavasiliou P.S., and Gellene R. Modification of parkinsonism: Chronic treatment with L-dopa. New England Journal of Medicine 280 (1969) 337-345
12. Crisostomo E.A., Duncan P.W., Propst M., Dawson D.V., and Davis J.N. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Annals of Neurology 23 (1988) 94-97
13. Dafotakis M., Grefkes C., Eickhoff S.B., Karbe H., Fink G.R., and Nowak D.A. Effects of rTMS on grip force control following subcortical stroke. Experimental Neurology (2008)
14. Defer G.L., Widner H., Marie R.M., Remy P., and Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders 14 (1999) 572-584
15. Edwards D.M., Pellizzoni C., Breuel H.P., Berardi A., Castelli M.G., Frigerio E., et al. Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding. Biopharmaceutics and Drug Disposition 16 (1995) 443-460
16. Feeney D.M., Gonzalez A., and Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217 (1982) 855-857
17. Gerdelat-Mas A., Loubinoux I., Tombari D., Rascol O., Chollet F., and Simonetta-Moreau M. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 27 (2005) 314-322
18. Gibbs M.E., and Summers R.J. Role of adrenoceptor subtypes in memory consolidation. Progress in Neurobiology 67 (2002) 345-391
19. Grefkes C., Nowak D.A., Eickhoff S.B., Dafotakis M., Kust J., Karbe H., et al. Cortical connectivity after subcortical stroke assessed with functional magnetic resonance imaging. Annals of Neurology 63 (2008) 236-246
20. Grefkes C., Ritzl A., Zilles K., and Fink G.R. Human medial intraparietal cortex subserves visuomotor coordinate transformation. Neuroimage 23 (2004) 1494-1506
21. Hallett M. Plasticity of the human motor cortex and recovery from stroke. Brain Research Brain Research Reviews 36 (2001) 169-174
22. Hegerl U., Mergl R., Henkel V., Pogarell O., Muller-Siecheneder F., Frodl T., et al. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression. Psychopharmacology 178 (2005) 58-66
23. Heinonen P., Koulu M., Pesonen U., Karvonen M.K., Rissanen A., Laakso M., et al. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. Journal of Clinical Endocrinology and Metabolism 84 (1999) 2429-2433
24. Herwig U., Brauer K., Connemann B., Spitzer M., and Schonfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology 164 (2002) 228-232
25. Hovda D.A., and Fenney D.M. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal-cortex injury in the cat. Brain Research 298 (1984) 358-361
26. Iaria G., Petrides M., Dagher A., Pike B., and Bohbot V.D. Cognitive strategies dependent on the hippocampus and caudate nucleus in human navigation: Variability and change with practice. Journal of Neuroscience 23 (2003) 5945-5952
27. Karni A., Meyer G., Rey-Hipolito C., Jezzard P., Adams M.M., Turner R., et al. The acquisition of skilled motor performance: Fast and slow experience-driven changes in primary motor cortex. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 861-868
28. Lange R., Weiller C., and Liepert J. Chronic dose effects of reboxetine on motor skill acquisition and cortical excitability. Journal of Neural Transmission 114 (2007) 1085-1089
29. Loubinoux I., Pariente J., Boulanouar K., Carel C., Manelfe C., Rascol O., et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: Double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage 15 (2002) 26-36
30. Loubinoux I., Pariente J., Rascol O., Celsis P., and Chollet F. Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects. Neuropsychologia 40 (2002) 1815-1821
31. Loubinoux I., Tombari D., Pariente J., Gerdelat-Mas A., Franceries X., Cassol E., et al. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. Neuroimage 27 (2005) 299-313
32. Martinsson L., Hardemark H., and Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Systematic Reviews (2007) CD002090
33. Martinsson L., Hardemark H.G., and Wahlgren N.G. Amphetamines for improving stroke recovery: A systematic Cochrane review. Stroke 34 (2003) 2766
34. Matelli M., and Luppino G. Parietofrontal circuits: Parallel channels for sensory-motor integrations. Advances in Neurology 84 (2000) 51-61
35. Meintzschel F., and Ziemann U. Modification of practice-dependent plasticity in human motor cortex by neuromodulators. Cerebral Cortex 16 (2006) 1106-1115
36. Miyai I., Saito T., Nozaki S., and Kang J. A pilot study of the effect of L-threodops on rehabilitation outcome of stroke patients. Neurorehabilitation and Neural Repair 14 (2000) 141-147
37. Muller U., von Cramon D.Y., and Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans. Journal of Neuroscience 18 (1998) 2720-2728
38. Nadeau S.E., Williamson D.J., Crosson B., Gonzalez Rothi L.J., and Heilman K.M. Functional imaging: Heterogeneity in task strategy and functional anatomy and the case for individual analysis. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 11 (1998) 83-96
39. Nishino K., Sasaki T., Takahashi K., Chiba M., and Ito T. The norepinephrine precursor L-threo-3,4-dihydroxyphenylserine facilitates motor recovery in chronic stroke patients. Journal of Clinical Neuroscience 8 (2001) 547-550
40. Nowak D.A., Grefkes C., Dafotakis M., Kust J., Karbe H., and Fink G.R. Dexterity is impaired at both hands following unilateral subcortical middle cerebral artery stroke. European Journal of Neuroscience 25 (2007) 3173-3184
41. Nudo R.J., Plautz E.J., and Frost S.B. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle and Nerve 24 (2001) 1000-1019
42. Plewnia C., Hoppe J., Cohen L.G., and Gerloff C. Improved motor skill acquisition after selective stimulation of central norepinephrine. Neurology 62 (2004) 2124-2126
43. Plewnia C., Hoppe J., and Gerloff C. No effects of enhanced central norepinephrine on finger-sequence learning and attention. Psychopharmacology 187 (2006) 260-265
44. Plewnia C., Hoppe J., Hiemke C., Bartels M., Cohen L.G., and Gerloff C. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neuroscience Letters 330 (2002) 231-234
45. Posner M.I., and Fan J. Attention as an organ system. In: Pomerantz J.R., and Crair M.C. (Eds). Topics in integrative neuroscience: From cells to cognition (2004), Cambridge University Press, Cambridge UK
46. Rajkowski J., Majczynski H., Clayton E., and Aston-Jones G. Activation of monkey locus coeruleus neurons varies with difficulty and performance in a target detection task. Journal of Neurophysiology 92 (2004) 361-371
47. Scheidtmann K., Fries W., Muller F., and Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: A prospective, randomised, double-blind study. Lancet 358 (2001) 787-790
48. Sparing R., Dafotakis M., Meister I.G., Thirugnanasambandam N., and Fink G.R. Enhancing language performance with non-invasive brain stimulation-A transcranial direct current stimulation study in healthy humans. Neuropsychologia 46 (2008) 261-268
49. Stibick D.L., and Feeney D.M. Enduring vulnerability to transient reinstatement of hemiplegia by prazosin after traumatic brain injury. Journal of Neurotrauma 18 (2001) 303-312
50. Svetkey L.P., Timmons P.Z., Emovon O., Anderson N.B., Preis L., and Chen Y.T. Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype. Hypertension 27 (1996) 1210-1215
51. Teasdale N., Bard C., Fleury M., Young D.E., and Proteau L. Determining movement onsets from temporal series. Journal of Motor Behavior 25 (1993) 97-106
52. Varri A.O., Grote L., Penzel T., Cassel W., Peter J.H., and Hasan J. A new method to study blood pressure, heart rate and EEG as a function of reaction time. Methods of Information in Medicine 33 (1994) 64-67
53. Vossel S., Thiel C.M., and Fink G.R. Behavioral and neural effects of nicotine on visuospatial attentional reorienting in non-smoking subjects. Neuropsychopharmacology 33 (2008) 731-738
54. Walker-Batson D., Smith P., Curtis S., Unwin H., and Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 26 (1995) 2254-2259
55. Ward N.S., Brown M.M., Thompson A.J., and Frackowiak R.S. Neural correlates of motor recovery after stroke: A longitudinal fMRI study. Brain 126 (2003) 2476-2496
56. Windle V., and Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Research 1044 (2005) 25-32
57. Winter D.A. Biomechanics and motor control of human movement. 2nd ed. (1990), Wiley, New York
58. Wong E.H.F., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F.P., Hoffmann W.P., et al. Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biological Psychiatry 47 (2000) 818-829
59. Ziemann U., Meintzschel F., Korchounov A., and Ilic T.V. Pharmacological modulation of plasticity in the human motor cortex. Neurorehabilitation and Neural Repair 20 (2006) 243-251
60. Zittel S., Weiller C., and Liepert J. Reboxetine improves motor function in chronic stroke. Journal of Neurology 254 (2007) 197-201